NCT00721643

CompletedEarly Phase 1

Absorption Kinetics of Polyphenols in Angel's Plant (Angelic...

Tufts University Source

Compare

Other study identifiers

Sponsor study identifier

HNRCA2580

Secondary identifiers

BioGreen 20070301034009

Study Type

interventional

Actual enrollment (reported)

10

Locations

1 country

Sites

1

Timeline

Study Start

July 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

March 2009

Actual (reported)

Study Completion

December 2010

Actual (reported)

Brief Summary

The absorption kinetics of polyphenols in angel's plant (Angelica keiskei), which is a dark green leafy vegetable rich in antioxidant nutrients, will be determined in older adults in this pilot study.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 10 participants
Study completion date: December 2010
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 22, 2008
Actual (reported)
First Posted
July 24, 2008
Actual (reported)
Primary Completion
March 2009
Actual (reported)
Study Completion
December 2010
Actual (reported)

Last Updated: April 25, 2017
Status Verified: April 2017
Last Update Submitted: April 24, 2017

Conditions

Oxidative Stress

Keywords

Angelica keiskeiabsorption kineticsquercetin

Outcome Measures

Primary Outcomes (1)

Plasma quercetin
0, 30, 60, 100, 180, 240, 300, 360, 420 & 480 min

Study Arms (2)

1

EXPERIMENTAL

Healthy control, 5g dry power of angel's plant (Angelica keiskei)

Dietary Supplement: angel's plant (Angelica keiskei)

2

EXPERIMENTAL

Metabolic syndrome, 5g dry powder of angel's plant (Angelica keiskei)

Dietary Supplement: Angel's plant (Angelica keiskei)

Interventions

angel's plant (Angelica keiskei)Dietary supplement

Healthy control, one time dose of 5g dry power of Angelica keiskei

1

Angel's plant (Angelica keiskei)Dietary supplement

Metaboic syndrome subjects, one time dose of 5g dry powder of angel's plant (Angelica keiskei)

2

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age60 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Healthy subjects (\>60 yr, n=5)
subjects with metabolic syndrome (\>60 yr, n=5)

Sponsors & Collaborators

Tufts University
Otherlead

Study Sites (1)

Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University

Boston, Massachusetts, 02111, United States

Study Officials

Kyung-Jin Yeum, Ph.D.
Tufts Medical Center
PRINCIPAL INVESTIGATOR

Enrollment

10 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: early phase 1
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: BASIC SCIENCE
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER

Study Record Dates

First Submitted

July 22, 2008

First Posted

July 24, 2008

Study Start

July 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT00253773

Metabolic Effects of Chemical Interactions in Toxicity

Not ApplicableCompleted

NCT00707330

Study of the Ability of Clarithromycin to Induce Oxidative Stress

Phase 1Completed

NCT00876811

Effect of Red Raspberry Consumption on Fasting Oxidative Stress Biomarkers

Phase 1Completed

NCT02172625

The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance

Not ApplicableCompleted

NCT01334424

Oxidative Stress in Robot-assisted Laparoscopic Radical Prostatectomy

Not ApplicableUnknown

NCT02432651

Xanthohumol and Prevention of DNA Damage

Phase 1Completed

Subjects who has

high fasting plasma glucose (\>5.6 mmol/L),

central obesity (waist-hip ratio, \>0.9 for men, \>0.85 for women)

either high blood pressure (\>130/85 mmHg) or high triacylglycerol (\>1.7 mmol/L) will be selected to have metabolic syndrome.

normal hematological parameters, normal serum albumin, normal liver function, and normal kidney function

no history of smoking or alcoholism.

You may not qualify if:

consume \>7 alcoholic drinks/wk
taking cholesterol medication or hormone replacement

Contact the study team to confirm eligibility.

Primary Completion

March 2009

Actual (reported)

Study Completion

December 2010

Actual (reported)

Last Updated

April 25, 2017

Record last verified: 2017-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00721643
Data provider: ClinicalTrials.gov
Source updated: 2017-04-25
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:26:54 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

1

2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations